zapotin: isolated from zapote blanco; structure in first source
ID Source | ID |
---|---|
PubMed CID | 629965 |
CHEMBL ID | 375582 |
CHEBI ID | 175322 |
SCHEMBL ID | 3307703 |
MeSH ID | M0507487 |
Synonym |
---|
CHEBI:175322 |
2-(2,6-dimethoxyphenyl)-5,6-dimethoxychromen-4-one |
flavone, 2',5,6,6'-tetramethoxy- |
5,6,2',6'-tetramethoxyflavone |
CHEMBL375582 , |
5,6,2'',6''-tetramethoxyflavone |
bdbm50202558 |
LMPK12110091 |
zapotin |
2-(2,6-DIMETHOXYPHENYL)-5,6-DIMETHOXY-4H-CHROMEN-4-ONE , |
14813-19-5 |
AKOS015906458 |
SCHEMBL3307703 |
2',6',5,6-tetramethoxyflavon |
PBQMALAAFQMDSP-UHFFFAOYSA-N |
4h-1-benzopyran-4-one, 2-(2,6-dimethoxyphenyl)-5,6-dimethoxy- |
2-(2,6-dimethoxyphenyl)-5,6-dimethoxy-4h-chromen-4-one # |
DTXSID80348078 |
2',5,6,6'-tetramethoxyflavone |
flavone,2',5,6,6'-tetramethoxy- |
FT-0766501 |
Q10861069 |
E77666 |
XZ161513 |
unii-z7cw4s27sb |
z7cw4s27sb , |
2-(2,6-dimethoxyphenyl)-5,6-dimethoxy-4h-1-benzopyran-4-one |
2-(2,6-dimethoxyphenyl)-5,6-dimethoxy-chromen-4-one |
AS-82604 |
Zapotin is a non-toxic inducer of cellular differentiation, apoptosis and cell cycle arrest with cultured HL-60 promyelocytic cells.
Excerpt | Reference | Relevance |
---|---|---|
"Zapotin is a non-toxic inducer of cellular differentiation, apoptosis and cell cycle arrest with cultured HL-60 promyelocytic cells." | ( Zapotin prevents mouse skin tumorigenesis during the stages of initiation and promotion. Craig, BA; Cuendet, M; Cushman, M; Maiti, A; Moon, RC; Oteham, CP; Pezzuto, JM, ) | 2.3 |
Excerpt | Reference | Relevance |
---|---|---|
"Zapotin treatment (IC50=2.74x10(-7 M)) resulted in a marked suppression of cell proliferation in the HT-29 cells." | ( Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis. Hirschelman, WH; Ito, A; Kinghorn, AD; Mehta, RG; Moriarty, RM; Murillo, G; Pezzuto, JM, 2007) | 2.5 |
Class | Description |
---|---|
ether | An organooxygen compound with formula ROR, where R is not hydrogen. |
flavonoids | Any organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Ornithine decarboxylase | Homo sapiens (human) | IC50 (µMol) | 3.4000 | 3.4000 | 4.0500 | 4.7000 | AID275747 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
kidney development | Ornithine decarboxylase | Homo sapiens (human) |
polyamine metabolic process | Ornithine decarboxylase | Homo sapiens (human) |
cell population proliferation | Ornithine decarboxylase | Homo sapiens (human) |
positive regulation of cell population proliferation | Ornithine decarboxylase | Homo sapiens (human) |
response to virus | Ornithine decarboxylase | Homo sapiens (human) |
putrescine biosynthetic process from ornithine | Ornithine decarboxylase | Homo sapiens (human) |
regulation of protein catabolic process | Ornithine decarboxylase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
ornithine decarboxylase activity | Ornithine decarboxylase | Homo sapiens (human) |
protein binding | Ornithine decarboxylase | Homo sapiens (human) |
protein homodimerization activity | Ornithine decarboxylase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
cellular_component | Ornithine decarboxylase | Homo sapiens (human) |
cytoplasm | Ornithine decarboxylase | Homo sapiens (human) |
cytosol | Ornithine decarboxylase | Homo sapiens (human) |
cytoplasm | Ornithine decarboxylase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID275751 | Upregulation of CD13 in human HL60 cell line | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275754 | Induction of apoptosis in human HL60 cell line after 24 hrs | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275752 | Upregulation of CD14 in human HL60 cell line | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275753 | Down-regulation of CD15 in human HL60 cell line | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275748 | Inhibition of TPA-induced NF-kappaB activity in HepG2 cells | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275758 | Cell cycle arrest in human HL60 cell line by accumulation at sub G1 phase | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275755 | Induction of apoptosis in human HL60 cell line at 12 uM | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275756 | Cell cycle arrest in human HL60 cell line by accumulation at S phase at 3 uM | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275757 | Cell cycle arrest in human HL60 cell line by accumulation at G2/M phase at 0.75 uM | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275747 | Inhibition of TPA-induced ODC activity in T24 cells | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275749 | Induction of differentiation in human HL60 cell line | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
AID275750 | Upregulation of CD11b in human HL60 cell line | 2007 | Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2 | Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.05) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (14.29%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |